Toxoplasmosis snapshots: Global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis

International Journal for Parasitology

Volumn 39, Issue 12, 2009, Pages 1385-1394

  Pappas, Georgios ^a,b   Roussos, Nikos ^a   Falagas, Matthew E ^a,c,d  

^a ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

^b Institute of Continuing Medical Education of Ioannina   (Greece)

^c HENRY DUNANT HOSPITAL   (Greece)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pregnancy; Seroprevalence; Toxoplasmosis

Indexed keywords

CHILDBEARING; DISEASE PREVALENCE; HEALTH POLICY; HEALTH STATUS; INFECTIOUS DISEASE; PARASITIC DISEASE; PREGNANCY; PUBLIC HEALTH; RISK FACTOR; SOCIOECONOMIC STATUS; WOMENS HEALTH;

ABORTION; AFRICA; ARTICLE; AWARENESS; CHILDBIRTH; CLIMATE; CONGENITAL TOXOPLASMOSIS; EASTERN EUROPE; ENVIRONMENTAL FACTOR; EUROPE; HEALTH CARE POLICY; HUMAN; IMMIGRATION; MEDICAL LITERATURE; MIDDLE EAST; NORTH AMERICA; PREGNANCY; PUBLIC HEALTH SERVICE; RISK FACTOR; SEROPREVALENCE; SOCIAL ASPECT; SOUTH AND CENTRAL AMERICA; SOUTHEAST ASIA; STILLBIRTH; TOXOPLASMA GONDII; UNITED STATES;

FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

AFRICA; ASIA; CENTRAL EUROPE; EASTERN EUROPE; EURASIA; EUROPE; LATIN AMERICA; MIDDLE EAST; SOUTHEAST ASIA;

TOXOPLASMA GONDII;

EID: 68049116940     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2009.04.003     Document Type: Article

References (146)

1. Abdi J., Shojaee S., Mirzaee A., and Keshavarz H. Seroprevalence of toxoplasmosis in pregnant women in Ilam province, Iran. Iran. J. Parasitol. 3 (2008) 34-37
2. Abu-Madi M.A., Al-Molawi N., and Behnke J.M. Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar. Parasitol. Vectors 1 (2008) 39
3. Acosta-Bas C., Perez X., and Garcia R. Presencia de anticuerpos IgG anti-Toxoplasma gondii en embarazadas residentes en la Ciudad de la Habana. Rev. Biomed. 12 (2001) 250-254
4. Adou-Bryn K.D., Ouhon J., Nemer J., Yapo C.G., and Assoumou A. Serological survey of acquired toxoplasmosis in women of childbearing age in Yopougon (Abidjan, Côte d'Ivoire). Bull. Soc. Pathol. Exot. 97 (2004) 345-348
5. Alexandrou M.E., Zagotzidou E., Voyatzi A., Katsigaraki S., Iconomidou C., Peppa A., and Petrocheilou V. A 4-year seroepidemiological screening for CMV, Rubella, and Toxoplasma infections among women of child-bearing age. Clin. Microbiol. Infect. 8 Suppl. 1 (2002) 282
6. Akoijam B.S., Shashikant S.S., and Kapoor S.K. Seroprevalence of Toxoplasma infection among primigravid women attending antenatal clinic at a secondary level hospital in North India. J. Indian Med. Assoc. 100 (2002) 591-592 594-596, 602
7. Al-Qurashi A.R., Ghandour A.M., Obeid O.E., Al-Mulhim A., and Makki S.M. Seroepidemiological study of Toxoplasma gondii infection in the human population in the Eastern Region. Saudi Med. J. 22 (2001) 13-18
8. Alvarado-Esquivel C., Sifuentes-Alvarez A., Narro-Duarte S.G., Estrada-Martinez S., Diaz-Garcia J.H., Liesenfeld O., Martinez-Garcia S.A., and Canales-Molina A. Seroepidemiology of Toxoplasma gondii infection in pregnant women in a public hospital in northern Mexico. BMC Infect. Dis. 6 (2006) 113
9. Angelo M.H. Legal dispositions and preventive strategies in congenital toxoplasmosis in Portugal. Arch. Pediatr. 10 Suppl. 1 (2003) 25-26
10. Antoniou M., Tzouvali H., Sifakis S., Galanakis E., Georgopoulou E., Liakou V., Giannakopoulou C., Koumantakis E., and Tselentis Y. Incidence of toxoplasmosis in 5532 pregnant women in Crete, Greece: management of 185 cases at risk. Eur. J. Obstet. Gynecol. Reprod. Biol. 117 (2004) 138-143
11. Asthana S.P., Macpherson C.N., Weiss S.H., Stephens R., Denny T.N., Sharma R.N., and Dubey J.P. Seroprevalence of Toxoplasma gondii in pregnant women and cats in Grenada, West Indies. J. Parasitol. 92 (2006) 644-645
12. Avelino M.M., Campos Jr. D., Parada J.B., and Castro A.M. Risk factors for Toxoplasma gondii infection in women of childbearing age. Braz. J. Infect. Dis. 8 (2004) 164-174
13. Baka S., Makrakis E., Hassiakos D., Logginidis I., Meretaki S., and Kouskouni E. Screening for Toxoplasma gondii, Rubella virus and Cytomegalovirus in pregnant women. Clin. Microbiol. Infect. 12 Suppl. 4 (2006) P873
14. Baril L., Ancelle T., Goulet V., Thulliez P., Tirard-Fleury V., and Carme B. Risk factors for Toxoplasma infection in pregnancy: a case-control study in France. Scand. J. Infect. Dis. 31 (1999) 305-309
15. Barrera A.M., Castiblanco P., Gomez J.E., Lopez M.C., Ruiz A., Moncada L., Reyes P., and Corredor A. Toxoplasmosis Adquirida Durante el Embarazo, en el Instituto Materno Infantil en Bogota. Rev. Salud Publica 4 (2002) 286-293
16. Bartolome Alvarez J., Martinez Serrano M., Moreno Parrado L., Lorente Ortuno S., and Crespo Sanchez M.D. Prevalence and incidence in Albacete, Spain, of Toxoplasma gondii infection in women of childbearing age: differences between immigrant and non-immigrant (2001-2007). Rev. Esp. Salud Publica 82 (2008) 333-342
17. Beccara L.A., Nicolini G., Tonolli E., Danzi M.C., and Concia E. Handling toxoplasmosis in pregnancy: the Verona experience. Clin. Microbiol. Infect. 11 Suppl. 2 (2005) 164
18. Benard A., Petersen E., Salamon R., Chene G., Gilbert R., Salmi L.R., and European Toxo Prevention Study Group (EUROTOXO). Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill. 13 (2008) 257-263
19. Birgisdottir A., Asbjornsdottir H., Cook E., Gislason D., Jansson C., Olafsson I., Gislason T., Jogi R., and Thjodleifsson B. Seroprevalence of Toxoplasma gondii in Sweden, Estonia and Iceland. Scand. J. Infect. Dis. 38 (2006) 625-631
20. Bobic B., Nikolic A., Klun I., Vujanic M., and Djurkovic-Djakovic O. Undercooked meat consumption remains the major risk factor for Toxoplasma infection in Serbia. Parassitologia 49 (2007) 227-230
21. Boia M.N., Carvalho-Costa F.A., Sodre F.C., Pinto G.M., and Amendoeira M.R. Seroprevalence of Toxoplasma gondii infection among Indian people living in Iauarete, Sao Gabriel da Cachoeira, Amazonas, Brazil. Rev. Inst. Med. Trop. Sao Paulo 50 (2008) 17-20
22. Borkakoty B.J., Borthakur A.K., and Gohain M. Prevalence of Toxoplasma gondii infection amongst pregnant women in Assam, India. Indian J. Med. Microbiol. 25 (2007) 431-432
23. Bossi P., and Bricaire F. Severe acute disseminated toxoplasmosis. Lancet 364 (2004) 579
24. Bouratbine A., Siala E., Chahed M.K., Aoun K., and Ben Ismail R. Sero-epidemiologic profile of toxoplasmosis in northern Tunisia. Parasite 8 (2001) 61-66
25. Breugelmans M., Naessens A., and Foulon W. Prevention of toxoplasmosis during pregnancy-an epidemiologic survey over 22 consecutive years. J. Perinat. Med. 32 (2004) 211-214
26. Breurec S., Berlioz-Arthaud A., Baumann E., Miegeville M., and Billaud E. Evaluation of toxoplasmosis seroprevalence among 2416 women of childbearing age followed at the Pasteur Institute of New Caledonia. Bull. Soc. Pathol. Exot. 97 (2004) 271-273
27. Buchy P., Follezou J.Y., Lien T.X., An T.T., Tram L.T., Tri D.V., Cuong N.M., Glaziou P., and Chien B.T. Serological study of toxoplasmosis in Vietnam in a population of drug users (Ho Chi Minh City) and pregnant women (Nha Trang). Bull. Soc. Pathol. Exot. 96 (2003) 46-47
28. Cabral, A.S.G., Balbino, F., Abdalla, L.F., Costa, S.S.S., Vaz, J.A.R., Fonseca, S.F., 2008. Seroprevalence of toxoplasmosis in women of reproductive age in the city of Brasilia, capital of Brazil. Abstracts, 13th International Congress of Infectious Diseases, Kuala Lumpur, Malaysia, June 2008, Abstract 179.
29. Carellos E.V., Andrade G.M., and Aguiar R.A. Evaluation of prenatal screening for toxoplasmosis in Belo Horizonte, Minas Gerais State, Brazil: a cross-sectional study of postpartum women in two maternity hospitals. Cad. Saude Publica 24 (2008) 391-401
30. Castro A.T., Congora A., and Gonzalez M.E. Toxoplasma gondii antibody seroprevalence in pregnant women from Villavicencio, Colombia. Orinoquia 12 (2008) 91-100
31. Chan B.T., Amal R.N., Hayati M.I., Kino H., Anisah N., Norhayati M., Sulaiman O., Abdullah M.M., Fatmah M.S., Roslida A.R., and Ismail G. Seroprevalence of toxoplasmosis among migrant workers from different Asian countries working in Malaysia. Southeast Asian J. Trop. Med. Public Health 39 (2008) 9-13
32. Chen X.G., Wu K., and Lun Z.R. Toxoplasmosis researches in China. Chin. Med. J. (Engl.) 118 (2005) 1015-1021
33. Cook A.J., Gilbert R.E., Buffolano W., Zufferey J., Petersen E., Jenum P.A., Foulon W., Semprini A.E., and Dunn D.T. Sources of Toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 321 (2000) 142-147
34. Contreras M., Schenone H., Salinas P., Sandoval L., Rojas A., Villarroel F., and Solis F. Seroepidemiology of human toxoplasmosis in Chile. Rev. Inst. Med. Trop. Sao Paulo 38 (1996) 431-435
35. Cursons R.M., Cepulis S., Naicker G., and Haslam A. The prevalence of Toxoplasma antibodies among pregnant women in Hamilton. N. Z. Med. J. 95 (1982) 536-537
36. de la Rosa M., Bolivar J., and Perez H.A. Toxoplasma gondii infection in Amerindians of Venezuelan Amazon. Medicina (B Aires) 59 (1999) 759-762
37. De Paschale M., Agrappi C., Clerici P., Mirri P., Manco M.T., Cavallari S., and Vigano E.F. Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy. Clin. Microbiol. Infect. 14 (2008) 186-189
38. Dhumne M., Sengupta C., Kadival G., Rathinaswamy A., and Velumani A. National seroprevalence of Toxoplasma gondii in India. J. Parasitol. 93 (2007) 1520-1521
39. Diza E., Frantzidou F., Souliou E., Arvanitidou M., Gioula G., and Antoniadis A. Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years. Clin. Microbiol. Infect. 11 (2005) 719-723
40. El Mansouri B., Rhajaoui M., Sebti F., Amarir F., Laboudi M., Bchitou R., Hamad M., and Lyagoubi M. Seroprevalence of toxoplasmosis in pregnant women in Rabat, Morocco. Bull. Soc. Pathol. Exot. 100 (2007) 289-290
41. Elnahas A., Gerais A.S., Elbashir M.I., Eldien E.S., and Adam I. Toxoplasmosis in pregnant Sudanese women. Saudi Med. J. 24 (2003) 868-870
42. Ertug S., Okyay P., Turkmen M., and Yuksel H. Seroprevalence and risk factors for Toxoplasma infection among pregnant women in Aydin province, Turkey. BMC Public Health 5 (2005) 66
43. European Food Safety Authority. Surveillance and monitoring of Toxoplasma in humans, food and animals. EFSA J. 583 (2007) 1-64
44. Evengard B., Petersson K., Engman M.L., Wiklund S., Ivarsson S.A., Tear-Fahnehjelm K., Forsgren M., Gilbert R., and Malm G. Low incidence of Toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol. Infect. 127 (2001) 121-127
45. Fallah M., Rabiee S., Matini M., and Taherkhani H. Seroepidemiology of toxoplasmosis in primigravida women in Hamadan, Islamic Republic of Iran, 2004. East. Mediterr. Health J. 14 (2008) 163-171
46. Farsaraki E., Spyridaki E., Anthousaki F., Tsapaki I., Pedioti A., Papagianaki A., and Liakou V. Serum profile of IgG and IgM antibodies towards Toxoplasma gondii in reproductive-age women: a laboratory view, 1995-99. Clin. Microbiol. Infect. 8 Suppl. 1 (2002) 287
47. Fan C.K., Liao C.W., Wu M.S., Su K.E., and Han B.C. Seroepidemiology of Toxoplasma gondii infection among Chinese aboriginal and Han people residing in mountainous areas of northern Thailand. J. Parasitol. 89 (2003) 1239-1242
48. Faye O., Leye A., Dieng Y., Richard-Lenoble D., and Diallo S. Toxoplasmosis in Dakar. Seroepidemiologic sampling of 353 women of reproductive age. Bull. Soc. Pathol. Exot. 91 (1998) 249-250
49. Ferguson W., Mayne P.D., Lennon B., Butler K., and Cafferkey M. Susceptibility of pregnant women to Toxoplasma infection - potential benefits for newborn screening. Ir. Med. J. 101 (2008) 220-221
50. Fiedler K., Hulsse C., Straube W., and Briese V. Toxoplasmosis-antibody seroprevalence in Mecklenburg-Western Pomerania. Zentralbl. Gynakol. 121 (1999) 239-243
51. Glynou I., Simou M., Avdeliodi K., Tzortzatou S., and Kada H. Seroepidemiology of toxoplasmosis in female population in Greece. Clin. Microbiol. Infect. 11 Suppl. 2 (2005) 164
52. Gutierrez-Zufiaurre N., Sanchez-Hernandez J., Munoz S., Marin R., Delgado N., Saenz M.C., Munoz-Bellido J.L., and Garcia-Rodríguez J.A. Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, Rubella virus, Hepatitis B and C Virus, and HIV in pregnant women. Enferm. Infecc. Microbiol. Clin. 22 (2004) 512-516
53. Han K., Shin D.W., Lee T.Y., and Lee Y.H. Seroprevalence of Toxoplasma gondii infection and risk factors associated with seropositivity of pregnant women in Korea. J. Parasitol. 94 (2008) 963-965
54. Harma M., Harma M., Gungen N., and Demir N. Toxoplasmosis in pregnant women in Sanliurfa, Southeastern Anatolia City, Turkey. J. Egypt. Soc. Parasitol. 34 (2004) 519-525
55. Havelaar A.H., Kemmeren J.M., and Kortbeek L.M. Disease burden of congenital toxoplasmosis. Clin. Infect. Dis. 44 (2007) 1467-1474
56. Hill D., and Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin. Microbiol. Infect. 8 (2002) 634-640
57. Hotez P.J. Neglected infections of poverty in the United States of America. PLoS Negl. Trop. Dis. 2 (2008) e256
58. Hung C.C., Fan C.K., Su K.E., Sung F.C., Chiou H.Y., Gil V., s Ferreira M., de Carvalho J.M., Cruz C., Lin Y.K., Tseng L.F., Sao K.Y., Chang W.C., Lan H.S., and Chou S.H. Serological screening and toxoplasmosis exposure factors among pregnant women in the Democratic Republic of Sao Tome and Principe. Trans. R. Soc. Trop. Med. Hyg. 101 (2007) 134-139
59. Hussein A.H., Ali A.E., Saleh M.H., Nagaty I.M., and Rezk A.Y. Prevalence of Toxoplasma infection in Qualyobia governorate, Egypt. J. Egypt. Soc. Parasitol. 31 (2001) 355-363
60. Iqbal J., Hira P.R., and Khalid N. Toxoplasmosis in Kuwait: improved diagnosis based on quantitative immuno-assay. Clin. Microbiol. Infect. 9 Suppl. 1 (2003) 336
61. Jara M., Hsu H.W., Eaton R.B., and Demaria Jr. A. Epidemiology of congenital toxoplasmosis identified by population-based newborn screening in Massachusetts. Pediatr. Infect. Dis. J. 20 (2001) 1132-1135
62. Jenum P.A., Stray-Pedersen B., Melby K.K., Kapperud G., Whitelaw A., Eskild A., and Eng J. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J. Clin. Microbiol. 36 (1998) 2900-2906
63. Jones J.L., Ogunmodede F., Scheftel J., Kirkland E., Lopez A., Schulkin J., and Lynfield R. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infect. Dis. Obstet. Gynecol. 11 (2003) 139-145
64. Jones J.L., Lopez B., Alvarez Mury M., Wilson M., Klein R., Luby S., and Maguire J.H. Toxoplasma gondii infection in rural Guatemalan children. Am. J. Trop. Med. Hyg. 72 (2005) 295-300
65. Jones J.L., Kruszon-Moran D., Sanders-Lewis K., and Wilson M. Toxoplasma gondii infection in the United States, 1999-2004, decline from the prior decade. Am. J. Trop. Med. Hyg. 77 (2007) 405-410
66. Jumaian N.F. Seroprevalence and risk factors for Toxoplasma infection in pregnant women in Jordan. East. Mediterr. Health J. 11 (2005) 45-51
67. Kankova S., and Flegr J. Longer pregnancy and slower fetal development in women with latent "asymptomatic" toxoplasmosis. BMC Infect. Dis. 7 (2007) 114
68. Kansouzidou A., Kaftantzi A., Vamvaka E., Koltsida M., and Karambaxoglou D. Laboratory diagnosis of Toxoplasma gondii infection in population in Northern Greece. Clin. Microbiol. Infect. 14 Suppl. 7 (2008) 720
69. Karunajeewa H., Siebert D., Hammond R., Garland S., and Kelly H. Seroprevalence of Varicella Zoster Virus, Parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management. Aust. N. Z. J. Obstet. Gynaecol. 41 (2001) 23-28
70. Kaur R., Gupta N., Nair D., Kakkar M., and Mathur M.D. Screening for TORCH infections in pregnant women: a report from Delhi. Southeast Asian J. Trop. Med. Public Health 30 (1999) 284-286
71. Kawashima T., Khin-Sane W., Kawabata M., Barzaga N., Matsuda H., and Konishi E. Prevalence of antibodies to Toxoplasma gondii among urban and rural residents in the Philippines. Southeast Asian J. Trop. Med. Public Health 31 (2000) 742-746
72. Kortbeek L.M., De Melker H.E., Veldhuijzen I.K., and Conyn-Van Spaendonck M.A. Population-based Toxoplasma seroprevalence study in The Netherlands. Epidemiol. Infect. 132 (2004) 839-845
73. Lago E.G., Conrado G.S., Piccoli C.S., Carvalho R.L., and Bender A.L. Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis. Eur. J. Clin. Microbiol. Infect. Dis. 28 (2009) 345-351
74. Leao P.R., Meirelles Filho J., and de Medeiros S.F. Toxoplasmosis: seroprevalence in postpartum women attended by SUS (Brazilian Public Health System). Rev. Bras. Ginecol. Obstet. 26 (2004) 627-632
75. Lebech M., Larsen S.O., and Petersen E. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand. J. Infect. Dis. 25 (1993) 751-756
76. Lebech M., Andersen O., Christensen N.C., Hertel J., Nielsen H.E., Peitersen B., Rechnitzer C., Larsen S.O., Norgaard-Pedersen B., and Petersen E. Feasibility of neonatal screening for Toxoplasma infection in the absence of prenatal treatment. Danish congenital toxoplasmosis study group. Lancet 353 (1999) 1834-1837
77. Lelong B., Rahelimino B., Candolfi E., Ravelojaona B.J., Villard O., Rasamindrakotroka A.J., and Kien T. Prevalence of toxoplasmosis in a population of pregnant women in Antananarivo (Madagascar). Bull. Soc. Pathol. Exot. 88 (1995) 46-49
78. Leroy, V., Hadjichristodoulou, C., 2005. Systematic review of risk factors for Toxoplasma gondii infection in pregnant women. Available from: (last accessed February 17, 2009).
79. Lin Y.L., Liao Y.S., Liao L.R., Chen F.N., Kuo H.M., and He S. Seroprevalence and sources of Toxoplasma infection among indigenous and immigrant pregnant women in Taiwan. Parasitol. Res. 103 (2008) 67-74
80. Liu Q., Wei F., Gao S., Jiang L., Lian H., Yuan B., Yuan Z., Xia Z., Liu B., Xu X., and Zhu X.Q. Toxoplasma gondii infection in pregnant women in China. Trans. R. Soc. Trop. Med. Hyg. 103 (2009) 162-166
81. Logar J., Petrovec M., Novak-Antolic Z., Premru-Srsen T., Cizman M., Arnez M., and Kraut A. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women. Scand. J. Infect. Dis. 34 (2002) 201-204
82. Machado I., Sousa I., and Angelo H. Congenital toxoplasmosis prevention in Portugal. Clin. Microbiol. Infect. 12 Suppl. 4 (2006) P872
83. Mahdi N.K., and Sharief M. Risk factors for acquiring toxoplasmosis in pregnancy. J. Bahrain Med. Soc. 14 (2002) 148-151
84. Maiga I., Kiemtore P., and Tounkara A. Prevalence of antitoxoplasma antibodies in patients with acquired immunodeficiency syndrome and blood donors in Bamako. Bull. Soc. Pathol. Exot. 94 (2001) 268-270
85. Martinez, R., Rodrigues, D., Casanova, P., Cox, R., Ginorio, D., Rodriguez, M., Fraga, J., 2005. Prevalencia de infeccion por Toxoplasma gondii en embarazadas de tres policlinicos del municipio Lisa. In: XII Congreso de la Asociacion Panamericana de Infectologia, May 2005, Caracas, Venezuela.
86. Marquez M.D.L.A., and Etcheverry I.S. Seroprevalence of toxoplasmosis in pregnant women in La Plata area. Acta Bioquim. Clin. Latinoam. 37 (2003) 413-415
87. Masini L., Casarella L., Grillo R.L., Zannella M.P., and Oliva G.C. Epidemiologic study on anti-Toxoplasma gondii antibodies prevalence in an obstetric population. Int. J. Gynaecol. Obstet. 20 (2008) 159-166
88. Mead P.S., Slutsker L., Dietz V., McCaig L.F., Bresee J.S., Shapiro C., Griffin P.M., and Tauxe R.V. Food-related illness and death in the United States. Emerg. Infect. Dis. 5 (1999) 607-625
89. Mela S., Tsigalou C., Gkioka T., Chrysafidou E., and Kampouromiti G. Seroprevalence of Rubella, Cytomegalovirus and Toxoplasma gondii among women of reproductive age in the region of Thrace, Greece. Clin. Microbiol. Infect. 10 Suppl. 3 (2004) 396
90. Messier V., Levesque B., Proulx J.F., Rochette L., Libman M.D., Ward B.J., Serhir B., Couillard M., Ogden N.H., Dewailly E., Hubert B., Dery S., Barthe C., Murphy D., and Dixon B. Seroprevalence of Toxoplasma gondii among Nunavik Inuit (Canada). Zoonoses Public Health 56 (2009) 188-197
91. Moese J.R., and Vander-Moese A. Mother-child pass in Austria and primary toxoplasmosis infections in pregnant women. Cent. Eur. J. Public Health 6 (1998) 261-264
92. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 (2004) 1965-1976
93. Morris A., and Croxson M. Serological evidence of Toxoplasma gondii infection among pregnant women in Auckland. N. Z. Med. J. 117 (2004) U770
94. Munoz Batet C., Guardia Llobet C., Juncosa Morros T., Vinas Domenech L., Sierra Soler M., Sanfeliu Sala I., Bosch Mestres J., Dopico Ponte E., Lite Lite J., Matas Andreu L., Juste Sanchez C., and Barranco Romeu M. Toxoplasmosis and pregnancy. Multicenter study of 16,362 pregnant women in Barcelona. Med. Clin. (Barc) 123 1 (2004) 2-16
95. Nabias R., Ngouamizokou A., Migot-Nabias F., Mbou-Moutsimbi R.A., and Lansoud-Soukate J. Serological investigation of toxoplasmosis in patients of the M.I.P. center of Franceville (Gabon). Bull. Soc. Pathol. Exot. 91 (1998) 318-320
96. Nash J.Q., Chissel S., Jones J., Warburton F., and Verlander N.Q. Risk factors for toxoplasmosis in pregnant women in Kent, United Kingdom. Epidemiol. Infect. 133 (2005) 475-483
97. Niemiec K.T., Raczynski P., Markiewicz K., Leibschang J., and Ceran A. The prevalence of Toxoplasma gondii infection among 2016 pregnant women and their children in the Institute of Mother and Child in Warsaw. Wiad. Parazytol. 48 (2002) 293-299
98. Nissapatorn V., Noor Azmi M.A., Cho S.M., Fong M.Y., Init I., Rohela M., Khairul Anuar A., Quek K.F., and Latt H.M. Toxoplasmosis: prevalence and risk factors. J. Obstet. Gynaecol. 23 (2003) 618-624
99. Nissapatorn V., and Abdullah K.A. Review on human toxoplasmosis in Malaysia: the past, present and prospective future. Southeast Asian J. Trop. Med. Public Health 35 (2004) 24-30
100. Nowakowska D., Stray-Pedersen B., Spiewak E., Sobala W., Malafiej E., and Wilczynski J. Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin. Microbiol. Infect. 12 (2006) 913-917
101. Ocak S., Zeteroglu S., Ozer C., Dolapcioglu K., and Gungoren A. Seroprevalence of Toxoplasma gondii, Rubella and Cytomegalovirus among pregnant women in southern Turkey. Scand. J. Infect. Dis. 39 (2007) 231-234
102. Olariu, T.R., Cretu, O., Darabus, G.H., Marincu, I., Jurovits, O., Erdelean, V., Tirnea, L., Neghina, R., Iacobiciu, I., Petrescu, C., Koreck, A., 2008. Screening for Toxoplasma gondii antibodies among women of childbearing age, in Timis County, Romania. Abstracts, 13th International Congress of Infectious Diseases, Kuala Lumpur, Malaysia, June 2008, Abstract 489.
103. Olbrich Neto J., and Meira D.A. Seroprevalence of HTLV-I/II, HIV, syphilis and toxoplasmosis among pregnant women seen at Botucatu - Sao Paulo - Brazil: risk factors for HTLV-I/II infection. Rev. Soc. Bras. Med. Trop. 37 (2004) 28-32
104. Pashazadeh, M., Tagizadeh, B., Rezaee, K., 2008. Evaluation of Toxoplasma gondii IgM & IgG antibodies among pregnant women by ELISA in Tabriz, Iran. Abstracts, 13th International Congress of Infectious Diseases, Kuala Lumpur, Malaysia, June 2008, Abstract 481.
105. Paul M., Petersen E., and Szczapa J. Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J. Clin. Microbiol. 39 (2001) 1912-1916
106. Porter S.B., and Sande M.A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327 (1992) 1643-1648
107. Porto A.M., Amorim M.M., Coelho I.C., and Santos L.C. Serologic profile of toxoplasmosis in pregnant women attended at a teaching-hospital in Recife. Rev. Assoc. Med. Bras. 54 (2008) 242-248
108. Pujol-Rique M., Quinto L., Danes C., Valls M.E., Coll O., and Jimenez De Anta M.T. Seroprevalence of toxoplasmosis in women of childbearing age, 1992-1999. Med. Clin. (Barc) 115 (2000) 375-376
109. Punda-Polic V., Tonkic M., and Capkun V. Prevalence of antibodies to Toxoplasma gondii in the female population of the County of Split Dalmatia, Croatia. Eur. J. Epidemiol. 16 (2000) 875-877
110. Rai S.K., Shibata H., Sumi K., Rai G., Rai N., Manandhar R., Gurung G., Ono K., Uga S., Matsuoka A., Shrestha H.G., and Matsumura T. Toxoplasma antibody prevalence in Nepalese pregnant women and women with bad obstetric history. Southeast Asian J. Trop. Med. Public Health 29 (1998) 739-743
111. Ramsewak S., Gooding R., Ganta K., Seepersadsingh N., and Adesiyun A.A. Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in Trinidad and Tobago. Rev. Panam. Salud Publica 23 (2008) 164-170
112. Reiche E.M., Morimoto H.K., Farias G.N., Hisatsugu K.R., Geller L., Gomes A.C., Inoue H.Y., Rodrigues G., and Matsuo T. Prevalence of American trypanosomiasis, syphilis, toxoplasmosis, rubella, hepatitis B, hepatitis C, human immunodeficiency virus infection, assayed through serological tests among pregnant patients, from 1996 to 1998, at the Regional University Hospital Norte do Parana. Rev. Soc. Bras. Med. Trop. 33 (2000) 519-527
113. Reis M.M., Tessaro M.M., and D'Azevedo P.A. Serologic profile of toxoplasmosis in pregnant women from a public hospital in Porto Alegre. Rev. Bras. Ginecol. Obstet. 28 (2006) 158-164
114. Rey L.C., and Ramalho I.L. Seroprevalence of toxoplasmosis in fortaleza, Ceara, brazil. Rev. Inst. Med. Trop. Sao Paulo 41 (1999) 171-174
115. Ricci M., Pentimalli H., Thaller R., Rava L., and Di Ciommo V. Screening and prevention of congenital toxoplasmosis: an effectiveness study in a population with a high infection rate. J. Matern. Fetal Neonatal Med. 14 (2003) 398-403
116. Rickard E., Costagliola M., Outen E., Cicero M., Garcia G., and Dieguez N. Toxoplasmosis antibody prevalence in pregnancy in Buenos Aires province, Argentina. Clin. Microbiol. Infect. 5 Suppl. 3 (1999) 171
117. Rodier M.H., Berthonneau J., Bourgoin A., Giraudeau G., Agius G., Burucoa C., Hekpazo A., and Jacquemin J.L. Seroprevalences of Toxoplasma, malaria, rubella, cytomegalovirus, HIV and treponemal infections among pregnant women in Cotonou, Republic of Benin. Acta Trop. 59 (1995) 271-277
118. Rosso F., Les J.T., Agudelo A., Villalobos C., Chaves J.A., Tunubala G.A., Messa A., Remington J.S., and Montoya J.G. Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Am. J. Trop. Med. Hyg. 78 (2008) 504-508
119. Russo A., Pirruccello B., Brunetti F., Massari G., Passalacqua O., and Reina M.G. Anti-toxoplasma antibody screening in women of reproductive age. Ig. Mod. 111 (1999) 559-565
120. Saeedi M., Veghari G.R., and Marjani A. Seroepidemiologic evaluation of anti-toxoplasma antibodies among women in North of Iran. Pak. J. Biol. Sci. 10 (2007) 2359-2362
121. Sagha, M., Daryani, A., 2004. Seroepidemiology of toxoplasmosis in women referred to Ardabil laboratory of Health Center for medical examines before marriage, Iran, 2002. Abstracts, 11th International Congress of Infectious Diseases, Cancun, Mexico, March 2004, Abstract 11.003.
122. Sanchez-Gutierrez A., Martin-Hernandez I., and Garcia-Izquierdo S.M. Estudio de reactividad a Toxoplasma gondii en embarazadas de las provincias Ciudad de la Habana y Pinar del Rio, Cuba. Bioquimia 28 (2003) 3-8
123. Shuhaiber S., Koren G., Boskovic R., Einarson T.R., Soldin O.P., and Einarson A. Seroprevalence of Toxoplasma gondii infection among veterinary staff in Ontario, Canada (2002): implications for teratogenic risk. BMC Infect. Dis. 3 (2003) 8
124. Simpore J., Savadogo A., Ilboudo D., Nadambega M.C., Esposito M., Yara J., Pignatelli S., Pietra V., and Musumeci S. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J. Med. Virol. 78 (2006) 730-733
125. Signorell L.M., Seitz D., Merkel S., Berger R., and Rudin C. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982-1999. Pediatr. Infect. Dis. J. 25 (2006) 123-128
126. Singh S., and Pandit A.J. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am. J. Reprod. Immunol. 52 (2004) 276-283
127. Song K.J., Shin J.C., Shin H.J., and Nam H.W. Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J. Parasitol. 43 (2005) 69-71
128. Spalding S.M., Amendoeira M.R., Klein C.H., and Ribeiro L.C. Serological screening and toxoplasmosis exposure factors among pregnant women in South of Brazil. Rev. Soc. Bras. Med. Trop. 38 (2005) 173-177
129. Studenicova C., Ondriska F., and Holkova R. Seroprevalence of Toxoplasma gondii among pregnant women in Slovakia Epidemiol. Mikrobiol. Imunol. 57 (2008) 8-13
130. Sukthana Y., Chintana T., Supathanapong W., Siripanth C., Lekkla A., and Chiabchalard R. Prevalence of toxoplasmosis in selected populations in Thailand. J. Trop. Med. Parasitol. 23 (2000) 53-58
131. Szenasi Z., Ozsvar Z., Nagy E., Jeszenszky M., Szabo J., Gellen J., Vegh M., and Verhofstede C. Prevention of congenital toxoplasmosis in Szeged, Hungary. Int. J. Epidemiol. 26 (1997) 428-435
132. Tabbara K.S., and Saleh F. Serodiagnosis of toxoplasmosis in Bahrain. Saudi Med. J. 26 (2005) 1383-1387
133. Taravati M., and Sadegkhalili F. Evaluation of anti-Toxoplasma gondii antibodies (IgG and IgM) in sera among the women before marriage in Urmia city, Iran. Clin. Microbiol. Infect. 9 Suppl. 1 (2003) 294
134. Tantivanich S., Amarapal P., Suphadtanaphongs W., Siripanth C., and Sawatmongkonkun W. Prevalence of congenital cytomegalovirus and toxoplasma antibodies in Thailand. Southeast Asian J. Trop. Med. Public Health 32 (2001) 466-499
135. Tenter A.M., Heckeroth A.R., and Weiss L.M. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30 (2000) 1217-1258
136. Terazawa A., Muljono R., Susanto L., Margono S.S., and Konishi E. High Toxoplasma antibody prevalence among inhabitants in Jakarta, Indonesia. Jpn. J. Infect. Dis. 56 (2003) 107-109
137. Triolo-Mieses M., and Traviezo-Valles L. Serological prevalence of Toxoplasma gondii antibodies in pregnancy in palavecino municipality. Lara State, Venezuela. Kasmera 34 (2006) 7-13
138. Uneke C.J., Duhlinska D.D., Njoku M.O., and Ngwu B.A. Seroprevalence of acquired toxoplasmosis in HIV-infected and apparently healthy individuals in Jos, Nigeria. Parassitologia 47 (2005) 233-236
139. Vaillant V., de Valk H., Baron E., Ancelle T., Colin P., Delmas M.C., Dufour B., Pouillot R., Le Strat Y., Weinbreck P., Jougla E., and Desenclos J.C. Foodborne infections in France. Foodborne Pathog. Dis. 2 (2005) 221-232
140. Varella I.M., Wagner M.B., Darela A.C., Nunes L.M., and Muller R.W. Seroprevalence of toxoplasmosis in pregnant women. J. Pediatr. (Rio J) 79 (2003) 69-74
141. Velasco-Castrejon O., Salvatierra-Izaba B., Valdespino J.L., Sedano-Lara A.M., Galindo-Virgen S., Magos C., Llausas A., Tapia-Conyer R., Gutierrez G., and Sepulveda J. Seroepidemiology of toxoplasmosis in Mexico. Salud Publica Mex. 34 (1992) 222-229
142. Wanachiwanawin D., Sutthent R., Chokephaibulkit K., Mahakittikun V., Ongrotchanakun J., and Monkong N. Toxoplasma gondii antibodies in HIV and non-HIV infected Thai pregnant women. Asian Pac. J. Allergy Immunol. 19 (2001) 291-293
143. Wong A., Tan K.H., Tee C.S., and Yeo G.S. Seroprevalence of Cytomegalovirus, Toxoplasma and Parvovirus in pregnancy. Singapore Med. J. 41 (2000) 151-155
144. Youssefi M.R., Sefidgar A.A., Mostafazadeh A., and Mahdavi Omran S. Serologic evaluation of toxoplasmosis in matrimonial women in Babol, Iran. Pak. J. Biol. Sci. 10 (2007) 1550-1552
145. Zapata M., Reyes L., and Holst I. Decreased prevalence of Toxoplasma gondii antibodies in adults form the Central Valley in Costa Rica. Parasitol. Latinoam. 60 (2005) 32-37
146. Zufferey J., Di Mito C., and Auckenthaler R. Evaluation of the new Vidia toxoplasmosis IgG and IgM assays in women of childbearing age. Clin. Microbiol. Infect. 13 Suppl. 1 (2007) 124